Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

Reprocessing single-use medical devices

By Bexis on December 19, 2006
Email this postTweet this postLike this postShare this post on LinkedIn

This article from the Minneapolis Star-Tribune reminded us of the simmering controversy about reprocessing medical devices that are labeled for single-use. Folks in the device and health care industries know the story: manufacturers produce certain medical devices labeled for single use only. Hospitals use the devices once; reprocessors sterilize the devices; and hospitals buy the sterilized devices and re-use them in new patients. Commentators raise issues about both whether the devices are safe when re-used and whether patients should be told as part of the informed consent process that they are being treated with reprocessed devices that were labeled for single use.

This is a tricky issue for us to discuss — not because we don’t have opinions, but because of who we are and what we do for a living. We typically represent drug and device manufacturers in product liability cases. But we both have colleagues who represent hospitals or other health care providers. And there’s always a chance that a reprocessor will call us one day, and who knows where zealous advocacy will lead then? So we won’t say publicly anything about the merits of the on-going debate.

We’ll say only this: As litigators, we’re called into action after smoldering issues like this one have ignited into legal infernos. And, if that ever happens here, all of the players in the single-use device controversy will look back with regret on the things they’ve said so stridently before the litigation began. A manufacturer’s protestation that a device labeled for single-use is unsafe if reprocessed, a hospital’s statement about the need to control costs, a reprocessor’s claim that manufacturers are just protecting profits — all of these comments can come back to haunt all of the players collectively.

Take it from a couple of guys who have been there and done that: Turn the volume down a notch, folks. It’s surely possible to discuss these issues without making accusations that may ultimately redound to everyone’s collective detriment. Be careful what you say in public; some day, you may be held to your words.

Photo of Bexis Bexis

JAMES M. BECK is Reed Smith’s only Senior Life Sciences Policy Analyst, resident in the firm’s Philadelphia office. He is the author of, among other things, Drug and Medical Device Product Liability Handbook (2004) (with Anthony Vale). He wrote the seminal law review…

JAMES M. BECK is Reed Smith’s only Senior Life Sciences Policy Analyst, resident in the firm’s Philadelphia office. He is the author of, among other things, Drug and Medical Device Product Liability Handbook (2004) (with Anthony Vale). He wrote the seminal law review article on off-label use cited by the Supreme Court in Buckman v. Plaintiffs Legal Committee. He has written more amicus briefs for the Product Liability Advisory Council than anyone else in the history of the organization, and in 2011 won PLAC’s highest honor, the John P. Raleigh award. He has been a member of the American Law Institute (ALI) since 2005. He is the long-time editor of the newsletter of the ABA’s Mass Torts Committee.  He is vice chair of the Class Actions and Multi-Plaintiff Litigation SLG of DRI’s Drug and Device Committee.  He can be reached at jmbeck@reedsmith.com.  His LinkedIn page is here.

Read more about BexisEmailJames's Linkedin Profile
Show more Show less
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Drug & Device Law
  • Organization:
    Drug & Device Law Blogging Team
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo